Cravacin (Deucravacitinib) is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
-
5 Publicações
-
1 fotos
-
0 Vídeos
-
Reside em 191/1, Bir Uttam Mir Shawkat SarakTejgaon C/A,Dhaka-1208, Bangladesh
-
Male
-
Seguido por 0 pessoas
Atualizações Recentes
-
Generic Ruxolitinib Topical Treatment for Eczema & VitiligoSkin conditions like atopic dermatitis (eczema) and vitiligo are more than just cosmetic concerns; they impact confidence, comfort, and quality of life. For years, patients relied on corticosteroids, which often came with risks of skin thinning and other side effects. The medical field has since evolved, introducing JAK inhibitors as a revolutionary way to treat these conditions at their...0 Comentários 0 Compartilhamentos 403 Visualizações 0 AnteriorFaça Login para curtir, compartilhar e comentar!
-
Ventoxen (Venetoclax): Targeted Cancer Therapy for CLL & AMLIn the rapidly evolving landscape of oncology, the shift from broad-spectrum treatments to precision medicine has redefined hope for patients. Among the most significant breakthroughs in recent years is Ventoxen (Venetoclax). As a highly specialized cancer therapy, Ventoxen offers a targeted approach to treating specific hematological malignancies, namely Chronic Lymphocytic Leukemia (CLL) and...0 Comentários 0 Compartilhamentos 344 Visualizações 0 Anterior
-
Affordable Resiliva (Resmetirom) for NASH Fibrosis – Buy OnlineNon-alcoholic steatohepatitis (NASH), now increasingly referred to as Metabolic Dysfunction-Associated Steatohepatitis (MASH), has long been a challenge for the medical community. For years, patients struggling with liver inflammation and advancing fibrosis had few direct treatment options beyond lifestyle changes. However, the introduction of Resmetirom, marketed under the brand name Resiliva,...0 Comentários 0 Compartilhamentos 297 Visualizações 0 Anterior
-
Cravacin (Deucravacitinib) 6mg: Generic TYK2 Inhibitor for PsoriasisThe landscape of plaque psoriasis treatment has witnessed a revolutionary shift with the introduction of TYK2 inhibitors. For millions of individuals living with moderate-to-severe plaque psoriasis, the daily struggle involves managing itchy, scaly, and often painful skin lesions. While topical creams and traditional systemic treatments have long been the standard, many patients seek a more...0 Comentários 0 Compartilhamentos 326 Visualizações 0 Anterior
-
0 Comentários 0 Compartilhamentos 279 Visualizações 0 Anterior
Mais Stories